Ha seleccionado la visión en Inglés
Descriptor en español: |
Heparina
| ||||||
Descriptor en inglés: | Heparin | ||||||
Descriptor en portugués: | Heparina | ||||||
Descriptor en francés: | Héparine | ||||||
Término(s) alternativo(s): |
Heparin Sodium Heparin, Sodium Heparin, Unfractionated Heparinic Acid Liquaemin Sodium Heparin Unfractionated Heparin alpha Heparin alpha-Heparin |
||||||
Código(s) jeráquico(s): |
D09.698.373.400 |
||||||
Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D006493 | ||||||
Nota de alcance: | A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. |
||||||
Calificadores permitidos: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AN analysis BI biosynthesis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis DF deficiency EC economics GE genetics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PH physiology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UL ultrastructure UR urine |
||||||
Combinación alternativa: |
antagonists & inhibitors:Heparin Antagonists
|
||||||
Acción Farmacológica: |
Anticoagulantes Fibrinolíticos |
||||||
Número de registro: | 9005-49-6 | ||||||
Nota Pública de MeSH: | /therapeutic use was HEPARIN, THERAPEUTIC 1965 |
||||||
Nota de historia: | /therapeutic use was HEPARIN, THERAPEUTIC 1965 |
||||||
Identificador de DeCS: | 23279 | ||||||
ID del Descriptor: | D006493 | ||||||
Clasificación de la NLM: | QV 193 | ||||||
Documentos indizados en la Biblioteca Virtual de Salud (BVS): | Haga clic aquí para acceder a los documentos de la BVS | ||||||
Fecha de establecimiento: | 01/01/1960 | ||||||
Fecha de entrada: | 01/01/1999 | ||||||
Fecha de revisión: | 25/06/2010 |
-
-
CHEMICALS AND DRUGS
Carbohydrates [D09]Carbohydrates
|
Heparin
- Concepto preferido
Liquaemin
- Más estrecho
Sodium Heparin
- Más estrecho
alpha-Heparin
- Más estrecho
UI del concepto |
M0010187 |
Nota de alcance | A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. |
Término preferido | Heparin |
Término(s) alternativo(s) |
Heparin, Unfractionated Heparinic Acid Unfractionated Heparin |
UI del concepto |
M0376235 |
Término preferido | Liquaemin |
UI del concepto |
M0010188 |
Término preferido | Sodium Heparin |
Término(s) alternativo(s) |
Heparin Sodium Heparin, Sodium |
UI del concepto |
M0010189 |
Término preferido | alpha-Heparin |
Término(s) alternativo(s) |
alpha Heparin |
Queremos sus comentarios sobre el nuevo sitio web de DeCS / MeSH
Lo invitamos a completar una encuesta que no tomará más de 3 minutos.
Ir a la encuesta